Peptide-drug conjugates and their targets in advanced cancer therapies

P Hoppenz, S Els-Heindl, AG Beck-Sickinger - Frontiers in chemistry, 2020 - frontiersin.org
Cancer became recently the leading cause of death in industrialized countries. Even though
standard treatments achieve significant effects in growth inhibition and tumor elimination …

International Union of Basic and Clinical Pharmacology. CV. Somatostatin receptors: structure, function, ligands, and new nomenclature

T Günther, G Tulipano, P Dournaud, C Bousquet… - Pharmacological …, 2018 - ASPET
Somatostatin, also known as somatotropin-release inhibitory factor, is a cyclopeptide that
exerts potent inhibitory actions on hormone secretion and neuronal excitability. Its …

Biological insights from the premonitory symptoms of migraine

N Karsan, PJ Goadsby - Nature Reviews Neurology, 2018 - nature.com
Migraine is a common neurological disorder with a diverse clinical phenotype that
comprises more than just head pain. Premonitory (prodromal) symptoms can start hours to …

[HTML][HTML] Physiology of cholangiocytes

JH Tabibian, AI Masyuk, TV Masyuk… - Comprehensive …, 2013 - ncbi.nlm.nih.gov
Cholangiocytes are epithelial cells that line the intra-and extrahepatic ducts of the biliary
tree. The main physiologic function of cholangiocytes is modification of hepatocyte-derived …

Resistance to somatostatin analogs in acromegaly

A Colao, RS Auriemma, G Lombardi… - Endocrine …, 2011 - academic.oup.com
Somatostatin analogs (SA) are widely used in acromegaly, either as first-line or adjuvant
treatment after surgery. First-line treatment with these drugs is generally used in the patients …

Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy

KE Öberg, JC Reubi, DJ Kwekkeboom, EP Krenning - Gastroenterology, 2010 - Elsevier
The incidence and prevalence of gastroenteropancreatic neuroendocrine tumors (GEP-
NETs) have increased in the past 20 years. GEP-NETs are heterogeneous tumors, in terms …

Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′, 5′-cyclic monophosphate

TV Masyuk, AI Masyuk, VE Torres, PC Harris… - Gastroenterology, 2007 - Elsevier
Background & Aims: In polycystic liver diseases (PCLDs), increased cholangiocyte
proliferation and fluid secretion are key features and cholangiocyte adenosine 3′, 5 …

Migraine and neuropeptides

J Tajti, D Szok, Z Majláth, B Tuka, A Csáti, L Vécsei - Neuropeptides, 2015 - Elsevier
Migraine is a common disabling neurovascular primary headache disorder. The
pathomechanism is not clear, but extensive preclinical and clinical studies are ongoing. The …

Quantitative analysis of somatostatin receptor subtype (SSTR1–5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas

GF Taboada, RM Luque, W Bastos… - European Journal of …, 2007 - academic.oup.com
Objective It is believed that the variable effectiveness of somatostatin analogs in post-
surgical management of somatotropinomas and non-functioning pituitary adenomas (NFPA) …

Modulation of pain transmission by G-protein-coupled receptors

HL Pan, ZZ Wu, HY Zhou, SR Chen, HM Zhang… - Pharmacology & …, 2008 - Elsevier
The heterotrimeric G-protein-coupled receptors (GPCR) represent the largest and most
diverse family of cell surface receptors and proteins. GPCR are widely distributed in the …